Literature DB >> 18247162

Estrogen replacement regimen and brain infusion of lipopolysaccharide differentially alter steroid receptor expression in the uterus and hypothalamus.

L K Marriott1, K R McGann-Gramling, B Hauss-Wegrzyniak, L C Sheldahl, R A Shapiro, D M Dorsa, G L Wenk.   

Abstract

The regimen of estrogen replacement can alter the consequences of estrogen therapy and stressors. To determine the long-term effects and interaction of these systems on the brain and periphery, adult female rats were infused with lipopolysaccharide (LPS) into the fourth ventricle of the brain for 4 weeks, and ovariectomized rats were administered either constant or pulsed regimens of estrogen replacement (17beta-estradiol) until sacrifice at 8 weeks. Constant, but not pulsed, estrogen replacement reduced ERalpha and increased HSP90, HSP70, and PR(B) uterine protein levels. Both estrogen regimens increased ERbeta, HSP27, and PR(A) uterine proteins. Both regimens reduced hypothalamic levels of ERalpha, but not ERbeta, HSP, or PR. No changes were observed in the hippocampus. Long-term brain infusion of LPS activated microglia and reduced body weight, but did not alter corticosterone or nitrotyrosine levels. LPS infusion into intact rats suppressed uterine weight, increased ERalpha and decreased HSP90 in the uterus. LPS did not alter uterine weight in ovariectomized rats treated with constant or pulsed estrogen. Together, these data suggest the timing of estrogen replacement and neuroinflammatory stressors can profoundly affect uterine and hypothalamic steroid receptor expression and may be important parameters to consider in the post-menopausal intervention with estrogen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18247162     DOI: 10.1007/s12020-008-9038-1

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  72 in total

1.  Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling.

Authors:  Ellinor Oxelmark; Roland Knoblauch; Suzzette Arnal; Laura F Su; Matthieu Schapira; Michael J Garabedian
Journal:  J Biol Chem       Date:  2003-06-30       Impact factor: 5.157

Review 2.  New insights regarding glucocorticoids, stress and gonadotropin suppression.

Authors:  Kellie M Breen; Fred J Karsch
Journal:  Front Neuroendocrinol       Date:  2006-05-19       Impact factor: 8.606

3.  Up-regulation of the peripheral-type benzodiazepine receptor expression and [(3)H]PK11195 binding in gerbil hippocampus after transient forebrain ischemia.

Authors:  V L Rao; K K Bowen; A M Rao; R J Dempsey
Journal:  J Neurosci Res       Date:  2001-06-01       Impact factor: 4.164

4.  Uterine decidual response occurs in estrogen receptor-alpha-deficient mice.

Authors:  B C Paria; J Tan; D B Lubahn; S K Dey; S K Das
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

5.  Coordinate regulation of neuropeptide Y and agouti-related peptide gene expression by estrogen depends on the ratio of estrogen receptor (ER) alpha to ERbeta in clonal hypothalamic neurons.

Authors:  Danny Titolo; Fang Cai; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2006-05-04

6.  The effect of intrauterine infusion of inflammation-provoking factors on proinflammatory cytokines and hormones in rat peripheral blood.

Authors:  B Jana; J Kucharski; M Jedlińska-Krakowska; E Wolińska-Witort
Journal:  Pol J Vet Sci       Date:  2005       Impact factor: 0.821

7.  Formation of nitrotyrosine by methylene blue photosensitized oxidation of tyrosine in the presence of nitrite.

Authors:  L Pecci; G Montefoschi; A Antonucci; M Costa; M Fontana; D Cavallini
Journal:  Biochem Biophys Res Commun       Date:  2001-11-23       Impact factor: 3.575

8.  Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression.

Authors:  Aleksandra Cvoro; Christina Tzagarakis-Foster; Deirdre Tatomer; Sreenivasan Paruthiyil; Mark S Fox; Dale C Leitman
Journal:  Mol Cell       Date:  2006-02-17       Impact factor: 17.970

9.  Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation.

Authors:  L K Marriott; B Hauss-Wegrzyniak; R S Benton; P D Vraniak; G L Wenk
Journal:  Behav Neurosci       Date:  2002-10       Impact factor: 1.912

10.  Expression and function of Toll-like receptor 4 in the endometrial cells of the uterus.

Authors:  Shan Herath; Deborah P Fischer; Dirk Werling; Erin J Williams; Sonia T Lilly; Hilary Dobson; Clare E Bryant; I Martin Sheldon
Journal:  Endocrinology       Date:  2005-10-13       Impact factor: 4.736

View more
  3 in total

1.  Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation.

Authors:  Matthew Kellom; Mireille Basselin; Vasken L Keleshian; Mei Chen; Stanley I Rapoport; Jagadeesh S Rao
Journal:  BMC Neurosci       Date:  2012-05-23       Impact factor: 3.288

2.  Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles.

Authors:  Liqin Zhao; Todd E Morgan; Zisu Mao; Sharon Lin; Enrique Cadenas; Caleb E Finch; Christian J Pike; Wendy J Mack; Roberta D Brinton
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

3.  Progesterone is essential for protecting against LPS-induced pregnancy loss. LIF as a potential mediator of the anti-inflammatory effect of progesterone.

Authors:  Julieta Aisemberg; Claudia A Vercelli; María V Bariani; Silvia C Billi; Manuel L Wolfson; Ana M Franchi
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.